A Randomized, Multicenter, Phase 2 Study of DSP-7888 Dos

Project: Research project

Project Details

Description

A Randomized, Multicenter, Phase 2 Study of DSP-7888 Dosing Emulsion Combination with Bevacizumab (Bev) versus Bevacizumab Alone in Patients with Recurrent or Progressive Glioblastoma following Initial Therapy
StatusActive
Effective start/end date6/1/176/30/21

Funding

  • BOSTON BIOMEDICAL, INC.

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.